These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 16873915)

  • 1. DOTS at a tertiary care center in northern India: successes, challenges and the next steps in tuberculosis control.
    Tahir M; Sharma SK; Rohrberg DS; Gupta D; Singh UB; Sinha PK
    Indian J Med Res; 2006 May; 123(5):702-6. PubMed ID: 16873915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised national TB control programme in India.
    Chauhan LS; Tonsing J
    Tuberculosis (Edinb); 2005; 85(5-6):271-6. PubMed ID: 16253562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme.
    Arora VK; Singla N; Sarin R
    Indian J Chest Dis Allied Sci; 2003; 45(4):231-5. PubMed ID: 12962456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of and barriers to public sector tuberculosis services in India.
    Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
    Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status and prospects of tuberculosis control in India.
    Khatri GR; Frieden TR
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):193-200. PubMed ID: 10751063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOTS centre at a tertiary care teaching hospital: lessons learned and future directions.
    Sharma SK; Lawaniya S; Lal H; Singh UB; Sinha PK
    Indian J Chest Dis Allied Sci; 2004; 46(4):251-6. PubMed ID: 15515825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised National Tuberculosis Control Programme: Indian perspective.
    Arora VK; Sarin R
    Indian J Chest Dis Allied Sci; 2000; 42(1):21-6. PubMed ID: 10851818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
    Tripathy S; Anand A; Inamdar V; Manoj MM; Khillare KM; Datye AS; Iyer R; Kanoj DM; Thakar M; Kale V; Pereira M; Risbud AR
    Indian J Med Res; 2011 May; 133(5):521-8. PubMed ID: 21623038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. India's Revised National Tuberculosis Control Programme: looking beyond detection and cure.
    Kelkar-Khambete A; Kielmann K; Pawar S; Porter J; Inamdar V; Datye A; Rangan S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):87-92. PubMed ID: 18173883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis is still a scourge of mankind--why?
    Rajasekaran A
    J Indian Med Assoc; 2012 May; 110(5):323-4. PubMed ID: 23360026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trend of pulmonary tuberculosis in patients seen at DOTS clinics in the Federal Capital Territory, Abuja, Nigeria.
    Bassey EB; Momoh MA; Imadiyi SO; Udofia EB; Miri FS; Anukam KC; Epoke J; Benka-Coker MO; Aluyi HS
    Public Health; 2005 May; 119(5):405-8. PubMed ID: 15780329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
    El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.